Coloplast results for the first half of 2009/10 show organic growth of 7% and
an EBIT margin of 20%. For the same period last year the EBIT margin was 15%.
Based on this Coloplast now expects an EBIT margin of 19-20% for 2009/10,
against the previous guidance of around 19%.
“We've had another strong result,” says CEO Lars Rasmussen. “We increased our
market share, and at the same time reached a very satisfactory profit.”
The improved earnings are, in large part, due to a much-improved production
economy, which is shown by the H1 gross margin of 61% against 58% last year.
”For quite some time now, we've been moving production from Denmark to Hungary
and China,” Rasmussen says. “This has been necessary in order to strengthen our
competitiveness, and therefore I am pleased that we now see the effect in
terms of lower production costs.”
With the interim results and the guidance for the year, Coloplast is well
underway to fulfill the company's long-term goal of at least a 20% EBIT margin.
That creates more profit to be invested in growth.
”Looking forward we will focus on increased growth through continued fast
product development and further sales force investments,” says Rasmussen. “And
I can promise that we'll remain focused on profit.”
For the year, Coloplast expects a revenue growth of 6-7% in both fixed
currencies and in DKK.
PRESS CONTACT
Morten Sørensen
Media Relations Manager
+45 4911 2632
dkmoso@coloplast.com
INVESTOR RELATIONS
Ian S. E. Christensen
Director of Investor Relations
+45 4911 1301
dkisec@coloplast.com
